These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21194475)

  • 1. Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses.
    Shim BS; Park SM; Quan JS; Jere D; Chu H; Song MK; Kim DW; Jang YS; Yang MS; Han SH; Park YH; Cho CS; Yun CH
    BMC Immunol; 2010 Dec; 11():65. PubMed ID: 21194475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
    Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
    J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
    Hu H; Lu X; Tao L; Bai B; Zhang Z; Chen Y; Zheng F; Chen J; Chen Z; Wang H
    Clin Vaccine Immunol; 2007 Jul; 14(7):894-901. PubMed ID: 17494640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain.
    Shim BS; Stadler K; Nguyen HH; Yun CH; Kim DW; Chang J; Czerkinsky C; Song MK
    Virol J; 2012 Sep; 9():215. PubMed ID: 22995185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal delivery of plasmids expressing bovine herpesvirus 1 gB/gC/gD proteins by polyethyleneimine magnetic beads activates long-term immune responses in mice.
    Liu XB; Yu GW; Gao XY; Huang JL; Qin LT; Ni HB; Lyu C
    Virol J; 2021 Mar; 18(1):60. PubMed ID: 33743745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice.
    Dong C; Wang Y; Zhu W; Ma Y; Kim J; Wei L; Gonzalez GX; Wang BZ
    ACS Appl Mater Interfaces; 2022 Feb; 14(5):6331-6342. PubMed ID: 35084819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments.
    Zeng F; Chow KY; Hon CC; Law KM; Yip CW; Chan KH; Peiris JS; Leung FC
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1134-9. PubMed ID: 14985131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
    Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
    J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus.
    Mu F; Niu D; Mu J; He B; Han W; Fan B; Huang S; Qiu Y; You B; Chen W
    BMC Microbiol; 2008 Nov; 8():207. PubMed ID: 19038059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface assembly of poly(I:C) on polyethyleneimine-modified gelatin nanoparticles as immunostimulatory carriers for mucosal antigen delivery.
    Lin SF; Jiang PL; Tsai JS; Huang YY; Lin SY; Lin JH; Liu DZ
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1228-1237. PubMed ID: 30339742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.
    Su LK; Yu F; Li ZF; Zeng C; Xu QA; Fan MW
    Acta Pharmacol Sin; 2014 May; 35(5):592-8. PubMed ID: 24705100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a eukaryotic expression plasmid encoding partial S gene fragments of the SARS-CoV and its potential utility as a DNA vaccine.
    He H; Tang Y; Qin X; Xu W; Wang Y; Liu X; Liu X; Xiong S; Li J; Zhang M; Duan M
    DNA Cell Biol; 2005 Aug; 24(8):516-20. PubMed ID: 16101350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice.
    King DF; McKay PF; Mann JF; Jones CB; Shattock RJ
    PLoS One; 2015; 10(11):e0141557. PubMed ID: 26544970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination.
    Cokarić Brdovčak M; Materljan J; Šustić M; Ravlić S; Ružić T; Lisnić B; Miklić K; Brizić I; Pribanić Matešić M; Juranić Lisnić V; Halassy B; Rončević D; Knežević Z; Štefan L; Bertoglio F; Schubert M; Čičin-Šain L; Markotić A; Jonjić S; Krmpotić A
    Eur J Immunol; 2022 Jun; 52(6):936-945. PubMed ID: 35304741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice.
    Hu MC; Jones T; Kenney RT; Barnard DL; Burt DS; Lowell GH
    Vaccine; 2007 Aug; 25(34):6334-40. PubMed ID: 17640780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive carbonate apatite nanoparticles as DNA vaccine carriers enhance humoral and cellular immunity.
    He P; Takeshima SN; Tada S; Akaike T; Ito Y; Aida Y
    Vaccine; 2014 Oct; 32(47):6199-205. PubMed ID: 25261380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.